Pure Global
NCT06036446

LATe Cerclage in High-risk Pregnancies (LATCH)

Cervical Cerclage for Short Cervix at 24-26 Weeks of Gestation: a Randomized Controlled Trial
Thomas Jefferson University·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Premature Birth
Drug/Device/Intervention
Cervical cerclage
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Thomas Jefferson University
Location
Philadelphia, United States of America
Timeline & enrollment
Phase
N/A
Start date
Nov 10, 2023
End date
Feb 01, 2027
Enrollment
329 participants
Primary outcome

Incidence of preterm birth 37 weeks

Summary

The goal of this clinical trial is to determine whether cervical cerclage reduces the risk of
 preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL)
 ≤25mm between 24 0/7-26 6/7 weeks.

ICD-10 classifications
Fetus and newborn affected by precipitate deliveryPreterm delivery without spontaneous labourDisorders related to short gestation and low birth weight, not elsewhere classifiedOther preterm infantsPreterm spontaneous labour with preterm delivery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06036446
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06036446 through Pure Global AI's free database. This phase not specified trial is sponsored by Thomas Jefferson University and is currently Recruiting. The study focuses on Premature Birth. Target enrollment is 329 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.